TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RZLT

Rezolute Inc

Healthcare · Biotechnology

3.90$ -1.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Rezolute Inc (RZLT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 125 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RZLT
Line item Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
11 10 9.9 11 11 9.8 6.3 5.1 2.5 1.1 0.5 15 12 27 21 15 11 7.4 39 33 43 39 83 70 152 156 150 134 124 113 102 88 133 123 112 95 175 159 139 125
4.5 3.7 3.8 4.8 4.9 4.4 1.2 0.4 2.0 0.8 0.4 15 12 26 20 14 11 6.9 38 32 42 38 78 64 152 156 148 106 105 103 96 82 129 110 99 89 171 155 135 122
4.1 3.4 3.6 4.4 4.5 4.0 0.9 0.1 1.6 0.4 0.3 15 12 25 20 14 10.0 6.4 38 32 41 37 77 63 150 154 147 34 16 8.1 13 5.9 70 10 8.9 15 94 9.1 12 11
4.1 3.4 3.6 4.4 4.5 4.0 0.9 0.1 – 0.4 0.3 15 12 25 20 14 – 6.4 38 32 41 37 77 63 150 154 147 103 102 99 93 80 127 108 97 87 168 152 133 120
– – – – – – – – – – – – – 0.2 – – – – – – – – – – – – – – – – – – – – – – 0.7 – 0.6 0.6
6.0 5.9 5.7 5.5 5.3 5.1 4.8 4.5 0.4 0.2 – 0.0 0.0 0.6 0.5 0.5 0.4 0.4 0.6 0.5 0.4 0.3 0.3 0.0 0.0 0.2 0.2 0.1 2.2 – – – – – – – – – – –
– – – – – – – – – 0.0 – -32 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – –
2.1 1.9 2.0 2.3 2.1 2.0 2.5 4.6 6.5 7.5 10 11 11 6.0 5.9 4.4 3.6 3.0 3.0 3.8 17 17 21 18 2.9 2.9 8.9 6.9 7.5 9.4 10 17 12 10.0 12 12 13 11 11 8.6
1.7 1.5 1.7 2.0 1.8 1.7 2.3 4.4 6.2 7.3 3.0 6.6 8.4 5.5 5.5 3.5 3.2 2.9 2.7 3.6 2.0 2.6 6.4 2.9 2.5 2.4 6.3 4.4 5.2 7.2 8.0 7.0 9.6 8.0 11 11 12 10 9.5 7.7
0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 3.4 4.1 0.0 0.0 0.0 0.2 0.2 0.2 – 0.2 0.3 0.3 0.3 0.2 0.1 0.1 0.1 0.1 0.2 0.3 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7
1.5 1.3 1.5 1.9 0.9 1.6 2.1 3.2 1.7 1.8 1.6 1.0 0.6 1.3 1.3 1.3 0.9 0.8 0.6 0.8 1.0 1.6 4.3 1.6 1.1 1.1 2.8 2.9 3.3 2.4 3.6 3.5 4.9 2.2 3.1 6.5 5.8 3.3 3.8 3.2
– – – – – – – – – – 5.0 – – – – – – – – – 14 14 14 15 0.4 – 0.4 0.4 – – – – – – – – – – – –
8.8 8.2 7.9 8.5 8.5 7.8 3.8 0.5 -4.0 -6.4 -9.8 4.6 1.8 21 15 10 7.4 4.4 36 29 26 22 62 52 149 153 141 127 116 104 92 71 121 113 100 83 162 147 128 117
-44 -48 -53 -58 -64 -71 -77 -82 -94 -98 -102 -124 -127 -132 -139 -144 -147 -151 -158 -162 -168 -176 -189 -200 -209 -219 -233 -248 -261 -276 -289 -306 -329 -345 -361 -379 -404 -422 -445 -461
0.7 0.7 0.8 0.8 1.1 1.1 1.1 1.2 1.2 1.2 1.2 1.2 5.4 5.4 5.9 5.9 5.9 5.9 8.0 8.4 8.4 8.5 16 17 19 51 51 51 51 51 51 51 51 70 70 70 94 103 104 104

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?